REQUEST A DEMO
Total
USD $0.00
Search more companies

Kainos Medicine, Inc. (South Korea)

Main Activities: Research and Development in Nanotechnology
Full name: Kainos Medicine, Inc. Profile Updated: May 15, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Kainos Medicine, Inc. is an enterprise based in South Korea. Its main office is in Seoul. The company operates in the Research and Development in Nanotechnology industry. It was established on November 03, 2017. It currently has a total number of 15 (2025) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 98.46% in 2025. Its total assets decreased by 38.4% over the same period. The net profit margin of Kainos Medicine, Inc. increased by 1400.42% in 2025.

Headquarters
82, Uisadang-Daero, Yeongdeungpo-Gu
Seoul; Seoul;

Contact Details: Purchase the Kainos Medicine, Inc. report to view the information.

Basic Information
Total Employees:
Purchase the Kainos Medicine, Inc. report to view the information.
Outstanding Shares:
Purchase the Kainos Medicine, Inc. report to view the information.
Registered Capital:
Purchase the Kainos Medicine, Inc. report to view the information.
Financial Auditors:
Purchase the Kainos Medicine, Inc. report to view the information.
Incorporation Date:
November 03, 2017
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
14.8%
Purchase this report to view the information.
5%
Subsidiaries
하나금융11호기업인수목적(주)
Company Performance
Financial values in the chart are available after Kainos Medicine, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
98.46%
Total Operating Revenue
N/A
Operating Profit
24.19%
EBITDA
31.8%
Net Profit/Loss for the Period
36.14%
Total Assets
-38.4%
Total Equity
-21.64%
Operating Profit Margin
1395.78%
Net Profit Margin
1400.42%
Return on Equity (ROE)
38.41%
Debt / Equity
-44.52%
Quick Ratio
1.21%
Cash Ratio
0.6%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?